Schedule 13G ownership disclosure
COGENT BIOSCIENCES INC
Common Stock, par value $0.001 per share · CUSIP: 19240Q201
Event date: 2025-09-30
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- TCG Crossover GP I, LLC
Shares: 6,798,162 · Class: 4.8%
- TCG Crossover Fund I, L.P.
Shares: 6,798,162 · Class: 4.8%
- Chen Yu
Shares: 6,798,162 · Class: 4.8%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001193125-25-283076
- Form type
- SCHEDULE 13G/A
- Filer
- Cogent Biosciences, Inc.
- CIK
- CIK 1622229
- Filed
- Nov 14, 2025
- Reporting period
- Sep 30, 2025
- Description
- Schedule 13G beneficial ownership